The first half of this presentation will further provide a review of various clinical trials to date, common imaging modalities for evaluation of CLTI and study endpoints.
TORONTO (PRWEB)
November 23, 2021
There are more than 200 million people living with peripheral artery disease (PAD) worldwide. Chronic Limb Threatening Ischemia (CLTI) represents the most advanced clinical condition among the spectrum of patients with PAD. CLTI is a highly morbid disease and associated with severe pain, ulcers and gangrene, impaired quality of life, amputations and mortality with a greater than $1 billion dollars healthcare cost per year.
In the first half of this webinar, Dr. Peter Schneider and Dr. David Deaton will provide attendees with an overview of the disease, an understanding to the social and financial cost, and provide a breakdown of the various procedures and technologies available for the evaluation and management of CLTI. The first half of this presentation will further provide a review of various clinical trials to date, common imaging modalities for evaluation of CLTI and study endpoints.
During the second half of the webinar, a speaker from Medical Metrics, Inc. (MMI) will discuss the clinical trial infrastructure for this type of study from an independent core lab’s perspective. MMI will discuss the requirements for an independent core lab for the image and data management, as well as the importance of properly monitoring sites for imaging protocol compliance and image quality thro
Join the founding partners of InRoad Medical, Peter Schneider, MD and David Deaton, MD; as well as Daniel Auger, PhD, Client Services Manager, Medical Metrics Inc., for the live webinar on Friday, December 10, 2021 at 9am EST (2pm GMT/UK) for a comprehensive overview of the clinical trial landscape for CLTI, including study design, imaging modalities and endpoint selection.
For more information, or to register for this event, visit Clinical Trial Design and Considerations for Below-the-Knee Interventions and Amputation Prevention.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Share article on social media or email: